Your privacy is important to us. Cookies are very small text files that are stored on your computer when you visit a website. We use cookies and other tracking technologies for a variety of purposes and to enhance your online experience on our website. You can change your preferences and decline certain types of cookies to be stored on your computer while browsing our website. You can also remove any cookies already stored on your computer, but keep in mind that deleting cookies may prevent you from using parts of our website. You can check our privacy policy page for more information.
-
press releaseWashington, D.C. (December 9, 2019) — The Pharmaceutical Research and Manufacturers of America (PhRMA) today initiated litigation in the United States District Court for the District of Oregon challenging House Bill No. 4005, 2018 Or. L. Ch. 7 (“HB 4005”) and House Bill No. 2658, 2019 Or. L. Ch. 436 (“HB 2658”), two unconstitutional Oregon laws. The following is a statement by PhRMA Executive Vice President and General Counsel James C. Stansel about the litigation:
“There is no doubt that people in Oregon and across the country are struggling to access and afford the health care they need. Unfortunately, HB 4005 and HB 2658 do nothing to help them. It is our hope that these misguided and unconstitutional policies are put aside so that we can instead focus on reforms that will actually help people better afford their medicines, such as capping out-of-pocket costs, making monthly costs more predictable and sharing negotiated savings on medicines with patients.”
PhRMA’s complaint argues that, separately and together, HB 4005 and HB 2658 violate the U.S. Constitution in several ways. Specifically:
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. Since 2000, PhRMA member companies have invested more than $900 billion in the search for new treatments and cures, including an estimated $79.6 billion in 2018 alone.
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.Innovation.org
www.GoBoldly.com
www.Facebook.com/PhRMA
www.Twitter.com/PhRMA
This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.